Breaking News

Celebrating 15 years of life-saving technology

The experts in temperature controlled packaging Peli BioThermal, are celebrating 15 years of the Original Golden Hour ...

Kick-starting QPSI's digital factory transformation

Quality Packaging Specialists Intíl (QPSI), a privately owned contract packaging company in the US, announces ...

New super barrier-coated thermoformable film for blister packs

Global packaging solutions expert Tekni-Films, introduces SBC 240 performance-oriented super-barrier coated ...

GDPR versus privacy: what you need to know

Collecting and sharing data from clients and customers is a mandatory element of driving todayís business, but ...

Sartorius and Penn State Uni announce partnership

Collaborative partnership to advance multidisciplinary teaching and research in biotechnology

Catalent Biologics and Valerius Biopharma to collaborate

The partnership will aim to develop and expand manufacture of Valeriusí biosimilar products

Standing strong

As regulatory pressure keeps rising, affecting every aspect of the drug manufacturing process, quality is an ongoing ...

BC Platforms partners with Google Cloud

The partnership will aim to deliver a highly scalable integrated genomic and clinical data solution to hospitals and ...

BC Platforms partners with Sentieon

The collaboration will aim to provide precision medicine solutions on a population scale

Serialisation: a new challenge with new and specific requirements

TraceLink recently launched its Global Drug Supply, Safety and Traceability Report, which included the results of a ...

Addressing glass particulates in injectable drug formulations

Glass particles are a frequent contaminant risk when producing injectable drugs on high speed filling lines. Glassmaker ...

Tips for choosing a 3D vision system

The future of vision systems in manufacturing

CordenPharma expands oligonucleotide API manufacturing

The expansion, which was completed in Q1 2018, will make the Colorado, US site one of the largest oligonucleotide ...

Biogen and Neurimmune announce option exercise for Aducanumab

The transaction will increase the profit potential of aducanumab for Biogen and provides near-term capital to Neurimmune